Faster, more accurate and more comfortable exams. 7
Technology that your patients will want to use.
Monitor accurately without compromising patient comfort and daily routine.
Wireless and water resistant
Online streaming
Validated algorithmic models
Loved by doctors and highly rated by patients.
Average rating of 4.7/5 for ease of use ⁸ and reliability.
Configure, create tests and manage continuous monitoring.
App Requestor
Continuous monitoring, more accurate diagnoses.
Study confirms: uninterrupted heart rhythm recording increases arrhythmia detection.1, 9
Diagnostic analysis flow aided by validated algorithmic models.
It identifies anomalies that are imperceptible to the human eye.
The validated algorithmic models are intended to assist doctors by highlighting potential arrhythmic events. The results are designed for interpretation and confirmation by qualified healthcare professionals and do not replace medical judgment.
Real-time capture and transmission via Bluetooth
Rapid analysis of large volumes of data 10
Identification of arrhythmia patterns 10
99% accuracy in identifying atrial fibrillation (AF) 7
ZERO initial investment
Technical support and training included in the subscription
Replacing the device, if necessary
Devices and charger at no extra cost
Payment per exam performed
More than 2,000 cardiologists prescribe QuoreOne in Brazil.
Why are cardiologists switching to QuoreOne?
Zero investment: subscription model and payment per exam.
Reduction in average diagnosis time from 45 to 4 days.
Comprehensive technical support: installation, training, maintenance and updates.
Up to 1.6 times higher diagnostic yield for severe arrhythmias with long-term monitoring. 4
Supporting doctors by highlighting potential arrhythmic events. 7
Intuitive digital platform for managing exams and accessing data in real time.
Expand your services: perform continuous cardiac monitoring from 24 hours to 7 days.
Completely wireless and online: no wires, memory cards or batteries to replace.
Greater patient compliance with the test, with a significant reduction in repetitions.
References
1. Worldometer, Current World Population, Available at: [https://www.worldometers.info/world-population/], Accessed on: April 25, 2025
2. Karamitanha F., et al, Difference Between Various Countries in Mortality and Incidence Rate of the Atrial Fibrillation Based on Human Development Index in Worldwide: Data From Global Burden of Disease 2010-2019, Current Problems in Cardiology Volume 48, Issue 1, January 2023
3. Van Gelder I. C, et al, 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal (2024) 00, 1-101, https://doi.org/10.1093/eurheartj/ehae176 and Risks, 1990-2022100000.
4.Known S., et al, Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study, J Med Internet Res. 2022 May; 24(5): e37970. Published online May 9, 2022. doi: 10.2196/37970: 10.2196/37970.
5. Kim J. Y., et al, The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring, Journal of Arrhythmia, Received: January 3, 2023 | Revised: April 13, 2023 | Accepted: April 20, 2023, DOI: 10.1002/joa3.12865.
6. Cadastro Nacional de Estabelecimentos de Saúde (CNES), Consulta Estabelecimentos, Nome com "COR" ou "CARDIO", mediana dos estabelecimentos, Available at: [https://cnes.datasus.gov.br/], accessed on 02May2025.
7. Hospital Israelita Albert Einstein, A Comparative study of an innovative 3-lead wireless water resistant Holter system and a conventional Holter system, Available at: [https://clinicaltrials.gov/study/NCT04723355?term=Quoretech&rank=1]; Accessed on: 25April2025
8. Data on file, Quoretech July/21
9. Yenikomshian M., et al, Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review, Curr Med Res Opin. 2019 Oct;35(10):1659-1670. doi: 10.1080/03007995.2019.1610370. Epub 2019 May 28.
10. Leclercq C., et al, Wearables, telemedicine and artificial intelligence in arrhythmias and heart failure: Proceedings of the Cardiovascular Roundtable of the European Society of Cardiology, EP Europace, Volume 24, Issue 9, September 2022, Pages 1372-1383, https://doi.org/10.1093/europace/euac05
11. ROL_ANS, Available at: [https://www.ans.gov.br/ROL-web/], Accessed on: 25April2025
12. SOBRAC, A vida de um portador de arrritmia cardíaca, Available at: [https://sobrac.org/publico-geral/sdrfvesfvs/], Accessed on: April 25, 2025
13. ANS, TISS Data Panel, Procedures 2024, Available at: [https://app.powerbi.com/view?r=eyJrIjoiZGVjMDI2NjItNTUzMS00OWJkLTgwNjMtOTJmNTVlYzYwMTg0IiwidCI6IjlkYmE0ODBjLTRmYTctNDJmNC1iYmEzLTBmYjEzNzVmYmU1ZiJ9], Accessed on: April 25, 2025
14. DATASUS, AMBULATORY PRODUCTION OF THE SUS - BRAZIL - BY PLACE OF CARE, HOLTER, Available at: [http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sia/cnv/qabr.def], Accessed on: 25April2025
The validated algorithmic models are intended to assist doctors by highlighting potential arrhythmic events. The results are designed for interpretation and confirmation by qualified healthcare professionals and do not replace medical judgment.
